Back to search

Netherlands· NL-555db9aefdfe

Ropivacaïne HCl B. Braun 7,5 mg/ml, oplossing voor injectie

A ropivacaine product containing ropivacaïnehydrochloride 1-water, registered in Netherlands by B. Braun Melsungen AG (Melsungen). The same ATC class is registered in 17 of our 19 countries.

ATC N01BB09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRopivacaïne HCl B. Braun 7,5 mg/ml, o…ATCN01BB09REGISTER NO.NL-555db9aefdfePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Ropivacaine is registered in 17 of 19 countries.

Countries holding a registration under ATC N01BB09 (ropivacaine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Ropivacaine · ATC N01BB09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ROPIVACAÏNEHYDROCHLORIDE 1-WATER
Manufacturer
B. Braun Melsungen AG (Melsungen)
Country
Netherlands (NL)
ATC code
N01BB09
ATC class
Ropivacaine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    105799

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for ropivacaine.

Graded by severity as the source publishes them — 46 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ropivacaine · interactions on record

106 records

  • 46 moderate
  • 46 minor
  • 14 info

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • Obeticholic acidA05AA04moderate
  • FostamatinibB02BX09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ropivacaine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ropivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ropivacain Diamed, Ropivacain Diamed Gmbh
  • Belgium · Ropivacain Hcl Noridem, Ropivacain Readyfusor Bioq Pharma
  • Bulgaria · Ропивакаин Hcl Б. Браун
  • Cyprus · Robicaine, Ropivacaine Kabi
  • Czechia · Ropivacaine Bioq
  • Germany · Naropin, Naropin Bag
  • Denmark · Ropivacain B. Braun, Ropivacain Fresenius Kabi
  • Estonia · Ropivacaine B. Braun, Ropivacaine Kabi
  • Spain · Ropivacaína Altan, Ropivacaína Altan Pharmaceuticals S.A.
  • Finland · Ropivacain Fresenius Kabi, Ropivacaine Bioq
  • France · Naropeine, Ropivacaine Alt An
  • United Kingdom (Northern Ireland) · Ropivacaine Altan, Ropivacaine Altan Pharmaceuticals S.A.
  • Greece · Ropivacain Hcl B. Braun, Ropivacaine /Kabi
  • Hungary · Naropin, Ropivacaine Fresenius Kabi
  • Ireland · Naropin, Ropivacaine
  • Italy · Ropivacaina Readyfusor Bioq, Ropivacaina B. Braun
  • Lithuania · Ropivacaine B. Braun, Ropivacaine Hydrochloride Kabi
  • Luxembourg · Ropivacain-Hcl B. Braun, Ropivacaine Fresenius Kabi
  • Latvia · Ropivacaine B. Braun, Ropivacaine Kabi
  • Malta · Ropivacaine Kabi
  • Norway · Ropivacain Fresenius Kabi, Ropivacaine Hikma
  • Poland · Ropimol, Ropivacaine Bioq
  • Portugal · Ropegen, Ropivacaína Altan
  • Romania · Ropivacaină Infomed, Ropivacaina Kabi
  • Sweden · Ropivacain Fresenius Kabi, Ropivacaine B. Braun
  • Slovenia · Ropivakain Readyfusor Bioq Pharma, Ropivakainijev Klorid Kabi
  • Slovakia · Ropivacaine Readyfusor Bioq Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cec27c4c-b28f-422b-a183-4886de04faf3
GET /v1/drugs/cec27c4c-b28f-422b-a183-4886de04faf3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Perineuraal gebruik, Epiduraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h105799_smpc.pdf",
  "strength": null,
  "atc_label": "Ropivacaine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg105799",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ROPIVACAÏNEHYDROCHLORIDE 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h105799.pdf",
  "authorised_at": "2012/06/27",
  "procedure_number": "DE/H/2536/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "105799",
  "additional_monitoring": "N"
}

See everything about ropivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.